Search Results
Found 7 results
510(k) Data Aggregation
(128 days)
MILLIKEN HEALTHCARE PRODUCTS, LLC
The ULTRA Silver Dressings are indicated for management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, and Stage I-IV dermal ulcers (vascular, venous, pressure, and diabetic).
The ULTRA Silver Dressings are sterile, single-use wound care dressings for use in moist wound management. The dressings are comprised of 4 layers, each performing a specific function; an occlusive synthetic top layer, a polyurethane foam layer, a hot-melt adhesive and a layer of a silver-containing knitted composite fabric.
The provided text is a 510(k) premarket notification for the ULTRA Silver Dressing, and it does not describe an AI medical device. Therefore, the requested information regarding acceptance criteria for an AI device, sample sizes for test and training sets, expert qualifications, adjudication methods, MRMC studies, or standalone algorithm performance cannot be extracted from this document.
The document discusses the substantial equivalence of the ULTRA Silver Dressing to a predicate device (AFM Ultra Ag Dressings) based on non-clinical performance testing.
Here's what can be extracted regarding the device performance and supporting studies, though it does not align with the AI device criteria requested:
Device: ULTRA Silver Dressing (Wound Dressing)
1. Table of Acceptance Criteria and Reported Device Performance:
The document doesn't explicitly state acceptance criteria in a numerical or statistical sense for wound dressings as one might for an AI device's performance metrics (e.g., sensitivity, specificity). Instead, it relies on demonstrating that the modified device, with changes to non-patient contacting layers, performs equivalently to the predicate device in terms of established performance categories.
Performance Category | Reported Device Performance (ULTRA Silver Dressings) |
---|---|
Biocompatibility | Fulfills prospectively defined performance criteria. |
Antimicrobial Effectiveness | Validation conducted; fulfills prospectively defined performance criteria. |
Sterility | Validation conducted; fulfills prospectively defined performance criteria. |
Fluid Management Performance | Fulfills prospectively defined performance criteria. |
Intended Use | Management of Partial- to Full Thickness Acute and Chronic Wounds (Same as predicate) |
Fabric Layer | Silver coated polyester/nylon/lycra (Same as predicate) |
Indications | Management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, and Stage I-IV dermal ulcers (Same as predicate) |
Antimicrobial Components | Silver sodium hydrogen zirconium phosphate (Same as predicate) |
Moisture Management Properties | Yes (Same as predicate) |
Conformable | Yes (Same as predicate) |
Multiple Day Use? | Yes (Same as predicate) |
Thickness | ≥ 4.0 mm (Predicate was ≥ 5.5 mm; this is a change, but no specific acceptance criterion is stated for it, implying the new thickness is acceptable). |
Porous Fabric Layer | Yes (Same as predicate) |
Contra-Indications | Known allergy to silver (Same as predicate) |
Packaging | Tyvek/Film Medical Pouch (Same as predicate) |
Sterilization | Gamma Irradiation (25 kGy) (Same as predicate) |
Study Description:
The study proving the device meets the "acceptance criteria" (understood as demonstrating substantial equivalence to the predicate device) is a "Summary of Non-Clinical Performance Testing."
Relevant Sections from the document:
-
Section 7: SUMMARY OF NON-CLINICAL PERFORMANCE TESTING AS BASIS FOR SUBSTANTIAL EQUIVALENCE
"Validation activities to support the use of the ULTRA Silver Dressings consisted of four main elements:- Biocompatibility Testing
- Validation of Antimicrobial Effectiveness
- Sterility Validation
- Fluid Management Performance
Testing of the ULTRA Silver Dressings has demonstrated that the wound dressing fulfills prospectively defined performance criteria and that the modification system meets user needs."
-
Section 8: SUMMARY OF CLINICAL TESTING AS BASIS FOR SUBSTANTIAL EQUIVALENCE
"No clinical testing was conducted to support this submission." -
Section 10: CONCLUSIONS DRAWN FROM NON-CLINICAL AND CLINICAL TESTS
"The similarities in intended use, operational characteristics, and functional technological characteristics between the proposed ULTRA Silver Dressings and the predicate AFM Ultra Ag Dressings lead to a conclusion of substantial equivalence between the proposed and predicate device."
Regarding the specific questions tailored for AI devices (which are not applicable here):
- Sample sizes used for the test set and the data provenance: Not applicable. This is a non-clinical device test, not an AI model evaluation.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. No ground truth in the AI sense is established.
- Adjudication method: Not applicable.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable.
- If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not applicable.
- The type of ground truth used: Not applicable. The "ground truth" here is the performance of the predicate device and established standards for wound dressing properties.
- The sample size for the training set: Not applicable.
- How the ground truth for the training set was established: Not applicable.
Ask a specific question about this device
(234 days)
MILLIKEN HEALTHCARE PRODUCTS, LLC
InterDry Textile is a skin protectant indicated for management of skin folds and other skin-to-skin contact areas. InterDry Textile reduces microbial colonization in the fabric.
InterDry is a non-sterile skin protectant fabric with an antimicrobial silver complex. InterDry is a single patient use product that is custom cut from a multiuse package.
Here's an analysis of the provided text, focusing on acceptance criteria and the study that proves the device meets those criteria:
Device: InterDry
1. Table of Acceptance Criteria and Reported Device Performance:
Acceptance Criteria Category | Specific Criteria/Tests Performed | Reported Device Performance |
---|---|---|
Material Safety | Biocompatibility | "suitable for its intended use" |
Antimicrobial Efficacy | Antimicrobial effectiveness testing | "reduces microbial colonization within the device itself" |
Physical Properties | Absorption | "substantially equivalent to the SurePress Absorbent Padding" |
Wicking | "substantially equivalent to the SurePress Absorbent Padding" | |
Friction | "substantially equivalent to the SurePress Absorbent Padding" | |
Silver release | "substantially equivalent to the SurePress Absorbent Padding" | |
Overall Suitability | Suitability for intended use | "suitable for its intended use" (based on physical testing) |
Substantial Equivalence | Comparison to predicate device (InterDry Textile with Silver K061615) | "identical" and "substantially equivalent in material, design, performance and indications for use" |
Comparison to predicate device (SurePress Absorbent Padding) | "substantially equivalent in design, function and intended use" |
2. Sample Size Used for the Test Set and Data Provenance:
The provided document does not specify the sample sizes used for any of the performance tests (biocompatibility, antimicrobial effectiveness, physical property testing).
The data provenance (e.g., country of origin, retrospective or prospective) is also not mentioned in this document.
3. Number of Experts Used to Establish Ground Truth and Qualifications:
The document does not mention using experts to establish ground truth for this device's performance testing. The evaluation appears to be based on laboratory testing against established standards or direct comparison to predicate devices, rather than expert interpretation of clinical data points.
4. Adjudication Method:
Since no expert input is mentioned for establishing ground truth, there is no adjudication method described.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
No, an MRMC comparative effectiveness study was not performed or mentioned in this document. The device is a "skin protectant" (medical fiber absorbent), and the nature of its testing (biocompatibility, antimicrobial, physical properties) does not typically involve human readers interpreting cases or AI assistance.
6. If a Standalone (algorithm only without human-in-the-loop performance) was done:
This question is not applicable as the InterDry is a physical medical device (textile) and not an AI algorithm. Therefore, "standalone algorithm performance" is not relevant to this submission. The performance tests conducted are inherently "standalone" in the sense that they evaluate the device itself without human intervention in the primary measurement.
7. The Type of Ground Truth Used:
The ground truth for this device's performance is established through:
- Standardized Biocompatibility Tests: These tests have predefined endpoints and acceptance criteria based on established international standards (ISO).
- Antimicrobial Effectiveness Test Standards: These tests measure the device's ability to reduce microbial colonization according to established laboratory protocols.
- Physical Property Measurement Standards: Absorption, wicking, friction, and silver release are measured against defined quantitative standards or directly compared to the predicate device's measured properties to demonstrate substantial equivalence.
8. The Sample Size for the Training Set:
This question is not applicable as the InterDry is a physical medical device and not an AI algorithm that requires a "training set."
9. How the Ground Truth for the Training Set was Established:
This question is not applicable as the InterDry is a physical medical device and not an AI algorithm.
Ask a specific question about this device
(88 days)
MILLIKEN HEALTHCARE PRODUCTS, LLC
Low Adherent AFM Ag Dressings are indicated for management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, and Stage I-IV dermal ulcers (vascular, venous, pressure and diabetic). The Low Adherent AFM Ag Dressings provide an antimicrobial barrier to microbial colonization in the dressing and reduce microbial penetration through the dressing.
The Low Adherent AFM Ag Dressings are sterile, single-use wound care dressings for use in moist wound management. The dressings are designed to contact the wound as a primary dressing and permit the passage of fluids. The dressings provide a protective environment for the wound and an effective protection against microbial contamination in the dressing. The devices are effective antimicrobial barrier dressings against both Gram-positive and Gram-negative bacteria, including the following organisms: methicillin-resistant Staphylococcus aureus (MRSA). methicillin- resistant Staphylococcus epidermidis (MRSE), vancomycin-resistant Enterococcus faecalis (VRE), Pseudomonas aeruginosa, and Acinetobacter baumannii.
The provided text does not describe a study that proves the device meets specific acceptance criteria in the context of typical medical device performance studies for diagnostic or therapeutic efficacy.
Instead, this document is a 510(k) Summary for a wound dressing, which focuses on substantial equivalence to a previously cleared predicate device. The "performance testing" mentioned is for validation activities rather than a comparative effectiveness or standalone performance study in the way one might expect for a diagnostic AI device.
Therefore, many of the requested sections about acceptance criteria, device performance, sample sizes, ground truth, and expert involvement are not applicable or cannot be extracted from this specific document.
Here's an attempt to answer the questions based on the available information, highlighting where the information is missing or not relevant to the requested structure:
Acceptance Criteria and Device Performance Study for Low Adherent AFM Ag Dressings
The provided 510(k) Summary for the Low Adherent AFM Ag Dressings describes validation activities to support the modified device, rather than a study with explicit acceptance criteria and device performance metrics as would typically be presented for a diagnostic or AI-driven device.
The core of this submission is to demonstrate substantial equivalence to a predicate device (Milliken Silver Wound Dressing, K051445) and to confirm that the modification (addition of a low adherent wound contact layer) does not affect safety and effectiveness.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Specific Acceptance Criteria | Reported Device Performance / Validation Achieved |
---|---|---|
Biocompatibility | Not explicitly stated | Biocompatibility Testing was conducted. |
Antimicrobial Effectiveness | Not explicitly stated, but inferred from predicate device's claims | Validation of Antimicrobial Effectiveness was conducted. The device is effective antimicrobial barrier against Gram-positive and Gram-negative bacteria, including MRSA, MRSE, VRE, Pseudomonas aeruginosa, and Acinetobacter baumannii. |
Sterility | Not explicitly stated | Sterility Validation was conducted. |
Overall Performance | Fulfill prospectively defined performance criteria; modified system meets user needs (post-modification). | "Testing... has demonstrated that the wound dressing fulfills prospectively defined performance criteria and that the modified system meets user needs." |
Substantial Equivalence | Device is identical to predicate except for low adherent layer; modification does not affect safety and effectiveness. | FDA found the device to be substantially equivalent to the predicate device K051445. |
Missing Information: Precise quantitative acceptance criteria (e.g., specific cytotoxicity thresholds, minimum microbial reduction percentages, or sterility assurance levels as defined in standards) are not detailed in this summary. The "reported device performance" is described qualitatively as "validation conducted" and meeting "prospectively defined performance criteria."
2. Sample Size Used for the Test Set and Data Provenance
This document does not describe a "test set" in the context of a performance study for a diagnostic or therapeutic effect. The validation activities (biocompatibility, antimicrobial effectiveness, sterility) typically involve standardized laboratory tests, for which sample sizes are determined by the specific test methods and regulatory standards (e.g., ISO, ASTM). The document does not provide these sample sizes or data provenance (country, retrospective/prospective) for these lab tests.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
Not applicable. The validation activities for a wound dressing (biocompatibility, antimicrobial effectiveness, sterility) do not involve expert-established "ground truth" in the way a diagnostic imaging study would. Standardized laboratory methods and controls are used.
4. Adjudication Method for the Test Set
Not applicable. No expert adjudication is described or relevant for these types of validation tests.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
No. An MRMC comparative effectiveness study is not relevant for a wound dressing and was not conducted or mentioned in this 510(k) summary. This type of study is typically for diagnostic devices, especially those involving human interpretation of data (e.g., radiology AI).
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This device is a physical wound dressing, not an algorithm or AI system.
7. The Type of Ground Truth Used
The concept of "ground truth" as pathology or outcomes data is not directly applicable here. For the described validation activities:
- Biocompatibility: Ground truth is established by standardized material safety tests and comparison to established safe materials or acceptable toxicity limits (e.g., ISO 10993 standards).
- Antimicrobial Effectiveness: Ground truth is established by laboratory cultures and validated methods for measuring microbial reduction or inhibition (e.g., ATCC strains, established protocols).
- Sterility: Ground truth is established by validated sterilization processes and sterility testing (e.g., USP guidelines, ISO 11137).
8. The Sample Size for the Training Set
Not applicable. This device is a physical wound dressing and does not involve a "training set" in the context of machine learning or AI.
9. How the Ground Truth for the Training Set was Established
Not applicable. As there is no training set, this question is not relevant.
Summary of Device Rationale from the Document:
The 510(k) describes a modification to an already cleared predicate device (Milliken Silver Wound Dressing K051445). The modification is the "addition of a low adherent wound contact layer." The key argument for substantial equivalence is that this modification is "minor and does not affect safety and effectiveness of the device." The "performance testing" (biocompatibility, antimicrobial effectiveness, sterility validation) was conducted to confirm that the modified device continues to meet expected performance criteria, implying these tests re-verified the properties of the device post-modification without necessarily presenting a new comparative efficacy study.
Ask a specific question about this device
(131 days)
MILLIKEN & CO.
AFM Ultra Ag Dressings are indicated for management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, and Stage I-1V dermal ulcers (vascular, venous, pressure and diabetic).
The AFM Ultra Ag Dressings are sterile, single-use wound care dressings for use in moist wound management. The dressings are comprised of 4 layers, each performing a specific function; an occlusive synthetic top layer, a polyurethane foam layer, a hotmelt adhesive and a layer of a silver-containing knitted composite fabric.
The provided document is a 510(k) summary for the AFM Ultra Ag Dressings. It focuses on demonstrating substantial equivalence to predicate devices rather than establishing novel performance criteria through a clinical study. Therefore, most of the requested information regarding acceptance criteria, study design, expert involvement, and ground truth establishment is not present in this type of submission.
However, I can extract the information that is available:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (Explicitly Stated or Implied) | Reported Device Performance |
---|---|
Biocompatibility (suitability for intended use) | "Results of the biocompatibility tests demonstrate that the device is suitable for its intended use." |
Antimicrobial effectiveness for the dressing | "Antimicrobial testing was performed which showed that AFM Ultra Ag Dressings provide an effective microbial barrier to the dressing itself." |
Substantial Equivalence in design, function, and intended use to predicate devices (K051445 and K022416) | "Milliken believes that the data included in this submission including the technical characteristics, physical properties, silver extraction, zone-of-inhibition and antimicrobial testing demonstrates that AFM Ultra Ag Dressings are substantially equivalent in design, function and intended use to Milliken Silver Wound Dressings (K051445) and Contreet Foam Adhesive/Nonadhesive (K022416)." |
Safety and Effectiveness (not adversely affected by construction/silver concentration differences) | "The differences between AFM Ultra Ag Dressings and the predicate devices include construction details and slightly different silver concentrations, which are minor and do not affect safety and effectiveness of the device, as demonstrated by the biocompatibility and efficacy testing." |
2. Sample size used for the test set and the data provenance:
- Not applicable. This submission relies on biocompatibility and in vitro antimicrobial testing, along with a comparison of technical characteristics to predicate devices. There is no mention of a clinical "test set" with patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable. No clinical test set with ground truth established by experts is described.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not applicable. No clinical test set is described.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. This device is a wound dressing, not an AI-powered diagnostic tool. MRMC studies are irrelevant here.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
- Not applicable. This device is a wound dressing, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- For biocompatibility: Ground truth would be established by standardized in vitro and in vivo biological evaluations according to ISO standards, assessing cellular response, irritation, sensitization, etc.
- For antimicrobial testing: Ground truth would be established by standardized microbiological assays (e.g., zone of inhibition, bacterial reduction tests) against specified microorganisms.
8. The sample size for the training set:
- Not applicable. This is not an AI/machine learning device.
9. How the ground truth for the training set was established:
- Not applicable. This is not an AI/machine learning device.
Ask a specific question about this device
(127 days)
MILLIKEN & CO.
The Silver Wound Pad is indicated for management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, lymphoedema, dermatological wounds, and Stage I-IV dermal ulcers (vascular, arterial, venous, pressure and diabetic).
The Silver Wound Pad is a sterile, single-use wound care dressing for use in moist wound management. The Silver Wound Pad is offered in several configurations including 24" x 36" and 36 " x 36" The dressings are comprised of 5 layers, each performing a specific function; an occlusive synthetic bottom layer (not in contact with patient), two absorbent layers, a layer of a knitted composite fabric (containing polyester on one side and nylon on the other side; coated with 15 ± 5% Antimicrobial AlphaSan® RC 2000 contained in a polyurethane binder) and a contact layer of apertured polyethylene film. These layers are then stitched or heat-sealed together along the edge.
The provided text is a 510(k) summary for the Silver Wound Pad, focusing on establishing substantial equivalence to a predicate device. It does not contain information about acceptance criteria, detailed device performance metrics in the way typically seen for AI/ML device studies, or the specific study design elements requested (like sample sizes for test/training sets, expert details for ground truth, or MRMC studies).
The "Performance Testing" section broadly states that "Biocompatibility testing was performed... Results... demonstrate that the device is suitable for its intended use. Antimicrobial testing was performed which showed that Silver Wound Pad provides efficacy against gram-positive and gram-negative bacteria." However, it does not provide quantitative acceptance criteria or detailed results of these tests.
Therefore, many of the requested fields cannot be directly extracted from the provided document.
Here's a breakdown of what can and cannot be answered based on the provided text:
Acceptance Criteria and Study Details for Silver Wound Pad
Information Requested | Details from the Document |
---|---|
1. Table of Acceptance Criteria & Reported Performance | Acceptance Criteria: Not explicitly stated in terms of quantitative metrics. The overall acceptance criterion appears to be "substantially equivalent" to the predicate device, implying that the safety and effectiveness are comparable. |
Reported Performance: |
- Biocompatibility: "Results of the biocompatibility tests demonstrate that the device is suitable for its intended use."
- Antimicrobial Activity: "Antimicrobial testing was performed which showed that Silver Wound Pad provides efficacy against gram-positive and gram-negative bacteria."
No specific numerical performance metrics (e.g., reduction percentage, zone of inhibition sizes) are provided. |
| 2. Sample Size (Test Set) and Data Provenance | Not applicable. This device is a wound dressing, not an AI/ML diagnostic. The "testing" mentioned refers to laboratory performance tests (biocompatibility, antimicrobial), not a clinical 'test set' in the AI sense. No information on sample sizes or data provenance for these lab tests is provided. |
| 3. Number of Experts & Qualifications (Ground Truth) | Not applicable. This is not an AI/ML device requiring expert-established ground truth for a diagnostic test set. |
| 4. Adjudication Method (Test Set) | Not applicable. |
| 5. MRMC Comparative Effectiveness Study | Not applicable. This is not an AI/ML device and therefore no MRMC study would be applicable. |
| 6. Standalone (Algorithm Only) Performance | Not applicable. This is a physical wound dressing and does not have an algorithm component. |
| 7. Type of Ground Truth Used | Not applicable. The "ground truth" for this device would be established by validated laboratory assays for biocompatibility and antimicrobial efficacy. |
| 8. Sample Size for Training Set | Not applicable. This is not an AI/ML device. |
| 9. How Ground Truth for Training Set was Established | Not applicable. |
Summary of the Study:
The "study" or "performance testing" described in the 510(k) submission for the Silver Wound Pad primarily consists of two types of laboratory tests:
- Biocompatibility Testing: Performed in accordance with International Organization for Standardization (ISO) recommendations. The results indicated the device's suitability for its intended use. No specific ISO standards or detailed results are provided.
- Antimicrobial Testing: Performed to demonstrate efficacy against gram-positive and gram-negative bacteria. The results showed the Silver Wound Pad "provides efficacy" against these bacteria. No specific test methods or quantitative results (e.g., bacterial reduction percentages or zones of inhibition) are mentioned.
The overarching "study" in the context of this 510(k) is the demonstration of substantial equivalence to the predicate device (Smith & Nephew Exu-Dry® Non-Permeable Pad). The biocompatibility and antimicrobial tests served to support the claim that the addition of a silver-based preservative does not negatively impact safety and effectiveness, and indeed provides an additional functional benefit (antimicrobial control) while maintaining overall equivalence in design, function, and intended use as a wound dressing. The acceptance criteria essentially boil down to passing these standard laboratory tests to a level that supports safety and efficacy for the stated intended use, and ultimately, allowing the FDA to determine substantial equivalence.
Ask a specific question about this device
(196 days)
MILLIKEN CHEMICAL
InterDry Textile with Silver is a skin protectant indicated for management of skin folds and other skin-to-skin contact areas. InterDry Textile with Silver reduces microbial colonization in the fabric.
Interdry Textile with Silver is a non-sterile skin protectant comprised of polyester knit textile substrate indicated for management of skin folds and other skin-to-skin contact areas and is offered as a 25.4 cm x 365.8 cm fabric piece, although other sizes may be available. The device provides moisture management to keep skin dry and the device's low coefficient of friction reduces skin-to-skin friction. Interdry Textile with Silver is a single patient use product that is custom cut from a multiuse package.
The provided text describes a 510(k) summary for the "Interdry Textile with Silver" device, which is a skin protectant. The performance testing section mentions "Biocompatibility testing" and "Antimicrobial testing". However, it does not provide detailed acceptance criteria with specific numerical targets, nor does it present a detailed study with a defined sample size, ground truth, or statistical analysis in the way typically expected for an AI/ML device.
It's important to note that K061615 is for a medical textile, not an AI/ML device. Therefore, the questions about AI/ML specific criteria (e.g., test set sample size, experts for ground truth, MRMC study, training set size) are not applicable to this submission. The "study" mentioned here refers to standard biocompatibility and antimicrobial efficacy tests for a medical textile.
Here's an attempt to answer the questions based on the available information, noting the limitations due to the nature of the device:
Acceptance Criteria and Device Performance for Interdry Textile with Silver (K061615)
This 510(k) submission is for a medical textile, not an AI/ML device. Therefore, many of the requested details, particularly those related to machine learning model evaluation, are not applicable. The reported performance relates to the physical and biological characteristics of the textile.
1. A table of acceptance criteria and the reported device performance
Acceptance Criteria Category | Specific Test/Attribute | Acceptance Criteria (Implied/General) | Reported Device Performance |
---|---|---|---|
Biocompatibility | Cytotoxicity, Sensitization, Irritation (typical for ISO 10993) | Suitable for intended use without adverse biological reactions | "Results of the Organization for biocompatibility tests demonstrate that the device is suitable for its intended use." |
Antimicrobial Efficacy (Device itself) | Reduction of microbial colonization within the fabric | Effective microbial barrier to the device itself | "Antimicrobial testing was performed which showed that Interdry Textile with Silver provides an effective microbial barrier to the device itself." |
Material Equivalence/Comparison to Predicate | Design, Function, Intended Use | Substantially equivalent to predicate in design, function, and intended use; additional feature does not affect safety/effectiveness. | "Substantially equivalent in design, function and intended use to the SurePress device." "The additional antimicrobial feature... does not affect the safety and effectiveness of the device." |
Physical Properties | Moisture management, low coefficient of friction | Provides moisture management to keep skin dry; reduces skin-to-skin friction. | "The device provides moisture management to keep skin dry and the device's low coefficient of friction reduces skin-to-skin friction." (Describes device function, not a specific test result here) |
Note: Specific numerical acceptance criteria for biocompatibility and antimicrobial tests are not provided in this summary. These would typically be detailed in the full submission, referencing standards like ISO 10993 for biocompatibility and specific microbiological test standards.
2. Sample size used for the test set and the data provenance
- Sample Size for Test Set: Not explicitly stated. For biocompatibility tests, sample sizes are dictated by the specific ISO 10993 test methods (e.g., animal tests, in-vitro cell cultures). For antimicrobial testing, sample sizes are typically small, involving various microbial strains and replicates.
- Data Provenance: Not explicitly stated but inferred to be laboratory-generated data from testing performed to industry standards. This is likely prospective testing conducted in controlled environments. Country of origin not specified.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- This question is not applicable to this type of device. "Ground truth" in the context of biocompatibility and antimicrobial testing is established by standard laboratory protocols and expert interpretation of results, not by a consensus of medical experts reviewing patient data. The "experts" would be the scientists and toxicologists performing and interpreting the laboratory tests according to established scientific principles and standards.
4. Adjudication method for the test set
- Not applicable. Adjudication methods like 2+1 or 3+1 typically refer to clinical outcome or image interpretation studies. For laboratory tests, results are interpreted based on predefined criteria in the test standard, often without external adjudication beyond internal quality control and peer review of results.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This is not an AI/ML device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not applicable. This is not an AI/ML device.
7. The type of ground truth used
- Ground Truth for Biocompatibility: Established by adherence to standardized testing protocols (e.g., ISO 10993 series for cytotoxicity, sensitization, irritation) and comparison against established biological reactivity scales. The "truth" is whether the material elicits a harmful biological response above acceptable thresholds.
- Ground Truth for Antimicrobial Efficacy: Established by quantitative microbiological assays that measure the reduction in microbial counts when in contact with the material, compared to control samples. The "truth" is the measured inhibition or kill rate of specific microorganisms.
8. The sample size for the training set
- Not applicable. There is no AI/ML model to train for this device.
9. How the ground truth for the training set was established
- Not applicable. There is no AI/ML model to train for this device.
Ask a specific question about this device
(81 days)
MILLIKEN CHEMICAL
The Milliken Silver Wound Dressings provide an antimicrobial barrier to microbial colonization in the dressing and reduce microbial penetration through the dressing. Milliken Silver Wound Dressings are indicated for management of partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, and Stage I-IV dermal ulcers (vascular, venous, pressure and diabetic).
Milliken's Silver Wound Dressings are sterile, single-use wound care dressings for use in moist wound management. The dressing consists of a nylon, lycra, and polyester continuous filament Jersey knit textile substrate which is pad coated with an aqueous suspension of silver sodium hydrogen zirconium phosphate (AlphaSan® RC-2000) and a polyurethane binder to provide an antimicrobial coating to the fabric. The textile substrate has a nylon face and polyester back providing a moisture affinity gradient across the thickness of the dressing.
Milliken Silver Wound Dressings are offered in several configurations including the following: 2" x 2", 4.25" x 4.25", 6" x 6", 1" x 24" and 4" x 48" (wrap).
Here's an analysis of the provided text regarding the Milliken Silver Wound Dressings, structured according to your request. Please note that the document is a 510(k) summary for a medical device cleared by the FDA, and as such, it focuses on demonstrating substantial equivalence to predicate devices rather than proving specific device performance against predefined acceptance criteria through a full-fledged clinical study in the way a novel drug or a high-risk AI algorithm might.
This document describes a wound dressing, which is a relatively low-risk device. The "performance testing" described is primarily to support the claim of substantial equivalence and safety, not to establish a precise performance metric like sensitivity or specificity.
Acceptance Criteria and Study Details for Milliken Silver Wound Dressings
1. Table of Acceptance Criteria and Reported Device Performance
Given that this is a 510(k) submission for a wound dressing, the "acceptance criteria" are not framed as specific numerical performance targets like sensitivity/specificity for an AI algorithm. Instead, the acceptance criteria are implicitly that the device is substantially equivalent to legally marketed predicate devices, demonstrating comparable safety and effectiveness.
Acceptance Criterion (Implicit for 510(k)) | Reported Device Performance (as demonstrated by testing) |
---|---|
Biocompatibility: Suitable for intended use (non-toxic, non-irritating). | Results: Biocompatibility testing performed in accordance with ISO recommendations demonstrated the device is suitable for its intended use. Specifically, the animal study indicated the test articles were "nonirritant as compared to the negative and comparative controls." |
Antimicrobial Barrier Effectiveness: Provides an effective microbial barrier to the dressing itself. | Results: Antimicrobial testing performed showed that the Milliken Wound Dressings provide an effective microbial barrier to the dressing itself. This aligns with the intended use statement: "provide an antimicrobial barrier to microbial colonization in the dressing and reduce microbial penetration through the dressing." The document references "zone-of-inhibition antimicrobial" testing, which is a standard method to demonstrate antimicrobial activity of substances. |
Wound Healing Characteristics: Does not impede normal wound healing. | Results: A full thickness wound healing study conducted using swine found that "All wounds appeared to heal without complication." Microscopically, "the test articles were considered nonirritant as compared to the negative and comparative controls." This indicates that the dressing did not negatively impact the healing process and was well-tolerated. |
Substantial Equivalence: Design, function, and intended use are similar to predicate devices, and differences do not affect safety and effectiveness. | Claim: Milliken believes that the data, including technical characteristics, physical properties, silver extraction, zone-of-inhibition antimicrobial and animal testing, demonstrates substantial equivalence to Argentum Medical LLC Silverlon® Wound Contact Dressing (K023612) and Westaim Biomedical Acticoat™ 7 Dressing (K001519). The FDA ultimately concurred with this claim, issuing the 510(k) clearance (K051445). |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size:
- Biocompatibility: Not specified beyond "testing was performed."
- Full Thickness Wound Healing Study (Swine): The specific number of swine or wounds is not explicitly stated. It mentions "swine in order to characterize the healing process."
- Antimicrobial Testing (Zone-of-Inhibition): Not specified.
- Data Provenance: The wound healing study was conducted using swine (animal data). Other tests (biocompatibility, antimicrobial) are general lab tests. There is no human clinical data presented in this summary.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
- Experts: Not explicitly mentioned in the context of establishing "ground truth" for the test results. For the animal study, the microscopic evaluation of irritation would typically be performed by a veterinary pathologist, but their number and qualifications are not specified nor is it described as "ground truth" in the AI sense.
4. Adjudication Method for the Test Set
- Adjudication Method: Not applicable. This document does not describe a process involving human judgment on diagnostic output, but rather laboratory and animal study results.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- MRMC Study: No, an MRMC comparative effectiveness study was not performed or described. This type of study is typically relevant for diagnostic imaging or AI algorithms where human readers interpret results.
6. Standalone Performance (Algorithm Only without Human-in-the-Loop)
- Standalone Performance: Not applicable. The device is a physical wound dressing, not a diagnostic algorithm. Therefore, "standalone performance" in the context of AI is not relevant. The device implicitly performs its function (antimicrobial barrier, wound healing support) "standalone" without human-in-the-loop interaction for its primary function once applied.
7. Type of Ground Truth Used
- Ground Truth: The "ground truth" here is based on biological outcomes (wound healing, non-irritation) and laboratory measurements (antimicrobial activity, biocompatibility metrics).
- For the wound healing study: The observation that "All wounds appeared to heal without complication" and microscopic findings that "the test articles were considered nonirritant" serve as the "ground truth" for the dressing's impact on healing in the animal model.
- For antimicrobial activity: The "zone-of-inhibition" results directly measure the antimicrobial efficacy, serving as ground truth for that specific property.
- For biocompatibility: The results from ISO-compliant tests establish the biological safety.
8. Sample Size for the Training Set
- Training Set Sample Size: Not applicable. This is a physical device, not an AI algorithm requiring a training set.
9. How the Ground Truth for the Training Set Was Established
- Training Set Ground Truth Establishment: Not applicable, as there is no training set for a physical wound dressing.
Ask a specific question about this device
Page 1 of 1